Browsing All Posts By Huntington Chile

06 Marzo 2018 RESUMEN SEMANAL DE NOTICIAS

Blocking Certain Glutamate Receptors Seen to Ease Huntington’s Advance in Mouse Model of Disease

Retrophin, Horizon Donate $3M Each to Rare Disease Institute at Children’s National

Emerald Health’s Huntington’s Therapy Candidate EHP-102 Granted FDA Orphan Drug Status

Huntington’s Patients’ Skin Cells Transformed Into Nerve Cells That Mimic Disease Symptoms

BioNews to Cover 3 Rare Disease Day Events, Including NIH Conference

READ MORE +